BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12736560)

  • 1. Molecular action of the estrogen receptor and hormone dependency in breast cancer.
    Iwase H
    Breast Cancer; 2003; 10(2):89-96. PubMed ID: 12736560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-independent interactions of p160/steroid receptor coactivators and CREB-binding protein (CBP) with estrogen receptor-alpha: regulation by phosphorylation sites in the A/B region depends on other receptor domains.
    Dutertre M; Smith CL
    Mol Endocrinol; 2003 Jul; 17(7):1296-314. PubMed ID: 12714702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer.
    Anzick SL; Kononen J; Walker RL; Azorsa DO; Tanner MM; Guan XY; Sauter G; Kallioniemi OP; Trent JM; Meltzer PS
    Science; 1997 Aug; 277(5328):965-8. PubMed ID: 9252329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
    Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
    J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
    Hudelist G; Czerwenka K; Kubista E; Marton E; Pischinger K; Singer CF
    Breast Cancer Res Treat; 2003 Mar; 78(2):193-204. PubMed ID: 12725419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different classes of coactivators recognize distinct but overlapping binding sites on the estrogen receptor ligand binding domain.
    Eng FC; Barsalou A; Akutsu N; Mercier I; Zechel C; Mader S; White JH
    J Biol Chem; 1998 Oct; 273(43):28371-7. PubMed ID: 9774463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
    Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
    Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of steroid receptor coactivator-1 and CREB binding protein in ligand-independent activity of estrogen receptor beta.
    Tremblay A; Giguère V
    J Steroid Biochem Mol Biol; 2001 Apr; 77(1):19-27. PubMed ID: 11358671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of steroid receptor coactivator AIB1 with estrogen receptor-alpha in breast cancer cells.
    Azorsa DO; Cunliffe HE; Meltzer PS
    Breast Cancer Res Treat; 2001 Nov; 70(2):89-101. PubMed ID: 11768608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptors: selective ligands, partners, and distinctive pharmacology.
    Katzenellenbogen BS; Montano MM; Ediger TR; Sun J; Ekena K; Lazennec G; Martini PG; McInerney EM; Delage-Mourroux R; Weis K; Katzenellenbogen JA
    Recent Prog Horm Res; 2000; 55():163-93; discussion 194-5. PubMed ID: 11036937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements.
    Hall JM; McDonnell DP; Korach KS
    Mol Endocrinol; 2002 Mar; 16(3):469-86. PubMed ID: 11875105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isoform-selective interactions between estrogen receptors and steroid receptor coactivators promoted by estradiol and ErbB-2 signaling in living cells.
    Bai Y; Giguére V
    Mol Endocrinol; 2003 Apr; 17(4):589-99. PubMed ID: 12554772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of coactivator expression by antisense oligodeoxynucleotides inhibits ERalpha transcriptional activity and MCF-7 proliferation.
    Cavarretta IT; Mukopadhyay R; Lonard DM; Cowsert LM; Bennett CF; O'Malley BW; Smith CL
    Mol Endocrinol; 2002 Feb; 16(2):253-70. PubMed ID: 11818499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.
    Kurebayashi J; Otsuki T; Kunisue H; Tanaka K; Yamamoto S; Sonoo H
    Clin Cancer Res; 2000 Feb; 6(2):512-8. PubMed ID: 10690532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential recruitment of coregulator proteins steroid receptor coactivator-1 and silencing mediator for retinoid and thyroid receptors to the estrogen receptor-estrogen response element by beta-estradiol and 4-hydroxytamoxifen in human breast cancer.
    Fleming FJ; Hill AD; McDermott EW; O'Higgins NJ; Young LS
    J Clin Endocrinol Metab; 2004 Jan; 89(1):375-83. PubMed ID: 14715875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
    Reiter R; Oh AS; Wellstein A; Riegel AT
    Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators.
    Lopez GN; Webb P; Shinsako JH; Baxter JD; Greene GL; Kushner PJ
    Mol Endocrinol; 1999 Jun; 13(6):897-909. PubMed ID: 10379889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanistic aspects of estrogen receptor activation probed with constitutively active estrogen receptors: correlations with DNA and coregulator interactions and receptor conformational changes.
    Lazennec G; Ediger TR; Petz LN; Nardulli AM; Katzenellenbogen BS
    Mol Endocrinol; 1997 Aug; 11(9):1375-86. PubMed ID: 9259327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G; Katzenellenbogen BS
    Mol Cell Endocrinol; 1999 Mar; 149(1-2):93-105. PubMed ID: 10375022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.